EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of Novel Compounds That Bind to the HGF β-Chain In Silico, Verification by Molecular Mechanics and Quantum Mechanics, and Validation of Their HGF Inhibitory Activity In Vitro

Ko Suzuki, Keitaro Inoue, Ryota Namiguchi, Seiya Morita, Suzuho Hayakawa, Mikuri Yokota, Katsuya Sakai iD, Kunio Matsumoto iD, Shunsuke Aoki iD

Molecules · 2025

DOI: 10.3390/molecules30081801 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Ko Suzuki und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioscience and Bioinformatics, Graduate School of Computer Science and Systems Engineering, Kyushu Institute of Technology, Iizuka 820-…. Hauptthemen laut MEDLINE: Hepatocyte Growth Factor, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Division of Tumor Dynamics and Regulation, Cancer Research Institute, Kanazawa University and Department of Bioscience and Bioinformatics, Graduate School…, Division of Tumor Dynamics and Regulation, Cancer Research Institute, Kanazawa University, Department of Bioscience and Bioinformatics, Graduate School of Computer Science and Systems Engineering, Kyushu Institute of Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of small-molecule drugs targeting growth factors for cancer therapy remains a significant challenge, with only limited successful cases. We attempted to identify hepatocyte growth factor (HGF) inhibitors as novel anti-cancer small-molecule drugs. To identify compounds that bind to the β-chain of HGF and inhibit signaling through HGF and its receptor Met interaction, we performed a hierarchical in silico drug screen using a three-dimensional compound structure library (Chembridge, 154,118 compounds). We experimentally tested whether 10 compounds selected as candidates for novel anticancer agents exhibit inhibition of HGF activity. Compounds 6 and 7 potently inhibited Met phosphorylation in the human EHEMES-1 cell line, with IC50 values of 20.4 and 11.9 μM, respectively. Molecular dynamics simulations of the Compound 6/7–HGF β-chain complex structures suggest that Compounds 6 and 7 stably bind to the interface pocket of the HGF β-chain. MM-PBSA, MM-GBSA, and FMO analyses identified crucial amino acid residues for inhibition against the HGF β-chain. By interfering with the HGF/Met interaction, these compounds may attenuate downstream signaling pathways involved in cancer cell proliferation and metastasis. Further optimization and comprehensive evaluations are necessary to advance these compounds toward clinical application in cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatocyte Growth FactorAntineoplastic AgentsHumansMolecular Dynamics SimulationProto-Oncogene Proteins c-metProtein BindingSmall Molecule LibrariesMolecular Docking SimulationPhosphorylationSignal TransductionCell Line, TumorQuantum TheoryBinding SitesCell ProliferationQuantum Mechanics

Stichwörter der Autor:innen

MDSMetSBDSfragment molecular orbitalhepatocyte growth factor (HGF)molecular docking

Substanzen

Hepatocyte Growth FactorProto-Oncogene Proteins c-metAntineoplastic AgentsHGF protein, humanSmall Molecule Libraries

Autor:innen und Institutionen

  • Department of Bioscience and Bioinformatics, Graduate School of Computer Science and Systems Engineering, Kyushu Institute of Technology, Iizuka 820-8502, Japan.
  • Division of Tumor Dynamics and Regulation, Cancer Research Institute, Kanazawa University, Kanazawa 920-1192, Japan.
  • WPI-Nano Life Science Institute, Kanazawa University, Kanazawa 920-1192, Japan.

ORCID-Profile: Katsuya Sakai, Kunio Matsumoto, Shunsuke Aoki

Förderung

  • The Division of Tumor Dynamics and Regulation, Cancer Research Institute, Kanazawa University and Department of Bioscience and Bioinformatics, Graduate School…
  • Division of Tumor Dynamics and Regulation, Cancer Research Institute, Kanazawa University
  • Department of Bioscience and Bioinformatics, Graduate School of Computer Science and Systems Engineering, Kyushu Institute of Technology

Zitieren

APA

Suzuki, K., Inoue, K., Namiguchi, R., Morita, S., Hayakawa, S., Yokota, M., Sakai, K., Matsumoto, K., & Aoki, S. (2025). Identification of Novel Compounds That Bind to the HGF β-Chain In Silico, Verification by Molecular Mechanics and Quantum Mechanics, and Validation of Their HGF Inhibitory Activity In Vitro. Molecules. https://doi.org/10.3390/molecules30081801

Vancouver

Suzuki K, Inoue K, Namiguchi R, Morita S, Hayakawa S, Yokota M, et al. Identification of Novel Compounds That Bind to the HGF β-Chain In Silico, Verification by Molecular Mechanics and Quantum Mechanics, and Validation of Their HGF Inhibitory Activity In Vitro. Molecules. 2025. doi:10.3390/molecules30081801

BibTeX
@article{Suzuki2025,
  author = {Suzuki, Ko and Inoue, Keitaro and Namiguchi, Ryota and Morita, Seiya and Hayakawa, Suzuho and Yokota, Mikuri and Sakai, Katsuya and Matsumoto, Kunio and Aoki, Shunsuke},
  title = {Identification of Novel Compounds That Bind to the HGF β-Chain In Silico, Verification by Molecular Mechanics and Quantum Mechanics, and Validation of Their HGF Inhibitory Activity In Vitro},
  journal = {Molecules},
  year = {2025},
  doi = {10.3390/molecules30081801}
}
Kostenlos starten →